Example: Heart Attack

Search clinical trials for: PR104

Total 6 results

  • NCT00862082
    Terminated
    Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)
    Conditions: Hepatocellular Carcinoma
  • NCT00862134
    Terminated
    Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC)
    Conditions: Non-Small Cell Lung Cancer
  • NCT00544674
    Terminated
    PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer
    Conditions: Lung Cancer
  • NCT01037556
    Unknown status
    PR104 in Treating Patients With Refractory/Relapsed Acute Leukemia
    Conditions: Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia
  • NCT00616213
    Completed
    PR104 and G-CSF in Treating Patients With Solid Tumors
    Conditions: Unspecified Adult Solid Tumor, Protocol Specific
  • NCT01358227
    Completed
    A Phase I Dose Escalation Trial of PR104 Given Weekly in Subjects With Solid Tumors
    Conditions: Unspecified Adult Solid Tumor, Protocol Specific

Medical Conditions

Sponsors and Collaborators

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations